NYSE:DVA DaVita Q3 2026 Earnings Date & Estimates $186.65 +0.55 (+0.30%) As of 10:14 AM Eastern This is a fair market value price provided by Massive. Learn more. DaVita is estimated to report Q3 2026 earnings on Thursday, October 29, 2026, after market closes. The conference call is scheduled for 5:00 PM ET. Research:ProfileEarnings HistoryForecast Upcoming Earnings Announcement QuarterQ3 2026Announcement DateOctober 29, 2026TimeAfter Market ClosesConference Call5:00 PM ET Add to CalendarGoogle Calendar (opens in a new tab)Outlook (opens in a new tab)Yahoo Calendar (opens in a new tab) What Analysts Expect from DaVita in Q3 2026DaVita is expected to post earnings of $3.57 per share on revenue of $3.52 billion. In the same quarter a year earlier DaVita reported $2.51 per share on revenue of $3.42 billion. DaVita last reported on August 4, 2026, posting $4.02 per share and beating the $3.88 consensus estimate. DaVita has beaten the consensus EPS estimate in 6 of its last 8 quarters.Consensus EstimatesConsensus EPS$3.57Expected Revenue$3.52 billionPrior-Year EPS$2.51Prior-Year Revenue$3.42 billionExpected EPS Growth+42.2%Expected Revenue Growth+2.8%Recent Track RecordLast ReportedQ2 2026Last Quarter EPS$4.02 (Beat by +$0.14)Last Quarter Revenue$3.55 billionEPS Beat Rate6 of last 8 quartersPrepare for the Q3 2026 CallEarnings HistoryCompany ProfileQ2 2026 Earnings ReportQ1 2026 Earnings ReportQ4 2025 Earnings Report DaVita Q3 2026 Earnings FAQ When does DaVita report Q3 2026 earnings? DaVita (NYSE:DVA) is estimated to report Q3 2026 earnings on Thursday, October 29, 2026, after market closes. This date is estimated from past reporting schedules and may change once the company confirms it. What time is DaVita's Q3 2026 earnings call? DaVita's Q3 2026 earnings conference call is scheduled for Thursday, October 29, 2026 at 5:00 PM ET. MarketBeat streams the conference call audio and posts the transcript as soon as possible on the earnings announcement date. What is the consensus EPS estimate for DaVita? Analysts expect DaVita to post earnings of $3.57 per share for Q3 2026. How much revenue is DaVita expected to report? The consensus revenue estimate for DaVita is $3.52 billion for Q3 2026. DaVita Earnings HeadlinesDaVita earnings preview: What to expectOctober 22 at 12:57 PM | msn.comOutpatient & specialty care stocks Q2 teardown: DaVita (NYSE:DVA) vs the restOctober 22 at 12:57 PM | finance.yahoo.comThe REAL Reason Trump is Invading IranFor a moment… Forget about Trump’s ties to Israel. Forget about reports of Iran’s nuclear program. Because my research has led me to believe we’re risking World War 3 with Iran for a completely different reason.October 23 at 1:00 AM | Banyan Hill Publishing (Ad)DaVita falls 6% amid proposed kidney care planOctober 20 at 11:12 PM | seekingalpha.comDaVita, Fresenius drop as HHS seeks dialysis market reformsOctober 20 at 6:11 PM | seekingalpha.comWhy DaVita (DVA) stock is nosedivingOctober 20 at 6:11 PM | msn.comSee More DaVita Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like DaVita? Sign up for Earnings360's daily newsletter to receive timely earnings updates on DaVita and other key companies, straight to your email. Email Address About DaVitaDaVita (NYSE:DVA) (NYSE: DVA) is a health care services company focused on kidney care. Through its DaVita Kidney Care business, the company provides outpatient dialysis treatments for people with chronic kidney failure, including in-center hemodialysis, home dialysis and related clinical support services. DaVita also offers integrated kidney care programs intended to support patients across the stages of chronic kidney disease. Its services may include care coordination, disease management, education, transplant support and other services designed to improve clinical outcomes and help manage the needs of patients with complex kidney conditions. The company operates a network of dialysis centers and related facilities in the United States and serves patients in select international markets. DaVita was established in 1994 as Total Renal Care and adopted the DaVita name in 2000. Its headquarters are in Denver, Colorado, and Javier Rodriguez serves as chief executive officer.View DaVita ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles Tractor Supply's Q3 Beat Plants the Seeds for a Stock ReboundWD-40 Could Reward Patient Investors—Here's WhyTexas Paused Data Center Hookups—2 Power Stocks Are Waiting on the VerdictIs Texas Instruments Setting Up for Its Next Big Breakout?Lam Research's Earnings Beat Wasn't the Real Story—Its 2027 Outlook WasTesla’s Flying-Car Hype Hits an Earnings Reality CheckMeta Bounces Back in Q3, But the Bigger Test Comes in 2027 Upcoming Earnings Verizon Communications (10/26/2026)Nucor (10/26/2026)Public Storage (10/26/2026)Welltower (10/26/2026)Cadence Design Systems (10/26/2026)Hilton Worldwide (10/27/2026)Royal Caribbean Cruises (10/27/2026)CocaCola (10/27/2026)Coca Cola Femsa (10/27/2026)Baker Hughes (10/27/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
